Literature DB >> 7820779

Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.

G Jablonski1, C C Danielsen, L Mosekilde, J O Gordeladze.   

Abstract

Predicting the course of parathormone (PTH)-elicited bone turnover in both humans and experimental rat models with moderate chronic uremia, using only standard clinical chemistry analyses, is often difficult. Consequently, rat bone from 1 + 2/3 nephrectomized animals, after 230 days of progressive renal failure, was examined for PTH-stimulated adenylate cyclase (AC) and phospholipase C (PL-C) activities. Correlations to biological parameters related to the function of bone and kidney were made. Reduced renal function was demonstrated by increased serum creatinine; circulating 1,25 dihydroxyvitamin D3 below detection level; diminished renal PTH-elicited AC activity; and decreased urinary cAMP excretion. PTH-activated renal PL-C was also reduced. However, no significant differences were seen in urine creatinine, calcium, phosphate, and hydroxyproline, nor in serum PTH, alkaline phosphatase, calcium, and phosphate. Notwithstanding, renal osteodystrophy developed as estimated by increased plasticity of the long bones, as well as reduction of the diaphyseal (Dd) and inner femoral mid-shaft (Di) diameters. Femoral cancellous bone exhibited a substantial elevation of both eroded surface (ES) and osteoid surface (OS) as well as a marked reduction in trabecular bone volume (TBV). Calvarial PTH-activated AC was enhanced, whereas corresponding PL-C was markedly reduced. PTH-enhanced AC correlated positively with ES and negatively with Di, respectively. PTH-enhanced PL-C, however, correlated positively with bone calcium content and negatively with ES. Our results indicate that bone modeling and remodeling are to a large extent related to PTH-elicited signaling systems, and cannot easily be predicted by standard clinical chemistry analyses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820779     DOI: 10.1007/bf00310407

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  35 in total

1.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

Authors:  H Jüppner; A B Abou-Samra; M Freeman; X F Kong; E Schipani; J Richards; L F Kolakowski; J Hock; J T Potts; H M Kronenberg
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

2.  Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells.

Authors:  A Fujimori; S L Cheng; L V Avioli; R Civitelli
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

3.  Parathyroid hormone inhibition of Na+/phosphate cotransport in OK cells: generation of second messengers in the regulatory cascade.

Authors:  G Quamme; J Pfeilschifter; H Murer
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

4.  A guanine nucleotide-dependent phosphatidylinositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes.

Authors:  S Jackowski; C W Rettenmier; C J Sherr; C O Rock
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

5.  A new experimental model for secondary hyperparathyroidism.

Authors:  J J Sancho; Q Y Duh; L Oms; A Sitges-Serra; M E Hammond; C D Arnaud; O H Clark
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

6.  1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.

Authors:  K H Klem; G Jablonski; O Saether; G Jarosz; K M Gautvik; J O Gordeladze
Journal:  Biochim Biophys Acta       Date:  1990-09-24

7.  Validation of a radioreceptor assay for 1,25-dihydroxyvitamin D using selected ion monitoring GC-MS.

Authors:  H Oftebro; J A Falch; I Holmberg; E Haug
Journal:  Clin Chim Acta       Date:  1988-08-31       Impact factor: 3.786

Review 8.  Review: Renal osteodystrophy--pathogenesis and treatment.

Authors:  H M Cushner; N D Adams
Journal:  Am J Med Sci       Date:  1986-04       Impact factor: 2.378

9.  The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.

Authors:  J O Gordeladze; B Mortensen; K Nordal; J Halse; E Dahl; L Aksnes; K M Gautvik
Journal:  Scand J Clin Lab Invest Suppl       Date:  1987

10.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  1 in total

1.  Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

Authors:  E M Greenfield; S M Shaw; S A Gornik; M A Banks
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.